Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and bay 41-4109

tenofovir has been researched along with bay 41-4109 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Goldmann, S; Li, J; Liu, X; Luo, Z; Ren, Q; Wang, C; Zhang, J; Zhang, Y1
Dong, Y; Jiang, C; Li, S; Liu, G; Ma, Y; Pei, Y; Tan, X; Wang, C; Wang, L; Xiang, Y1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

3 other study(ies) available for tenofovir and bay 41-4109

ArticleYear
Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
    Bioorganic & medicinal chemistry, 2017, 02-01, Volume: 25, Issue:3

    Topics: Administration, Oral; Animals; Antiviral Agents; Capsid; Crystallography, X-Ray; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Viral; Hep G2 Cells; Hepatitis B virus; Humans; Models, Molecular; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Thiazoles

2017
Discovery of (1
    Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11

    Topics: Animals; Antiviral Agents; Binding Sites; Capsid; Capsid Proteins; Cell Line; DNA, Viral; Drug Design; Drug Resistance, Viral; Hepatitis B virus; Humans; Mice; Microsomes, Liver; Protein Structure, Tertiary; Pyrazoles; Pyridines; Solubility; Structure-Activity Relationship; Sulfonamides; Virus Assembly; Virus Replication

2020
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023